Pluristem Therapeutics Inc.

Overview

Pluristem Therapeutics Inc. is a biotechnology company that specializes in the development of placenta-based cell therapy products. The company's proprietary technology platform focuses on producing highly potent allogeneic cell products for the treatment of numerous high-impact indications.

Therapeutic areas

Regenerative MedicineHematologyMusculoskeletal Disorders

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Pluristem Therapeutics Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Pluristem Therapeutics Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.